NYSE:CLDI | Free Cash Flow | Calidi Biotherapeutics, Inc.

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2021-06-30 to 2026-03-31
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2026-03-31-$4.12M
2025-12-31-$5.04M
2025-03-31-$7.13M
2024-12-31-$5.42M
2024-03-31-$3.83M
2023-12-31-$5.19M
2023-03-31-$3.11M
2022-12-31-$3.88M
2022-03-31-$465,131.00
2021-06-30-$118,804.00

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-12-31-$21.29M
2024-12-31-$19.69M
2023-12-31-$26.98M
2022-12-31-$13.21M